Search details
1.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30796151
2.
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?
Crit Rev Oncol Hematol
; 157: 103167, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33271389
3.
Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer.
Cancers (Basel)
; 12(5)2020 May 13.
Article
in English
| MEDLINE | ID: mdl-32413973
4.
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study.
Oncoimmunology
; 9(1): 1710389, 2020.
Article
in English
| MEDLINE | ID: mdl-32002308
5.
New therapeutic targets in pancreatic cancer.
Cancer Treat Rev
; 81: 101926, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31739115
6.
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
Clin Lung Cancer
; 20(4): 237-247.e1, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30885550
7.
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.
J Immunother Cancer
; 7(1): 57, 2019 02 27.
Article
in English
| MEDLINE | ID: mdl-30813970
8.
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study.
Immunotherapy
; 10(8): 643-655, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29562816
9.
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.
Immunotherapy
; 10(14): 1229-1239, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30326787
Results
1 -
9
de 9
1
Next >
>>